Panitumumab Antibody
Panitumumab is a fully human IgG2 monoclonal antibody that specifically binds to and inhibits the epidermal growth factor receptor (EGFR) . It is widely used in both in vitro and in vivo research to study EGFR-driven cancers, including colorectal cancer, and to investigate mechanisms of targeted therapy.
Product Specifications
Product Name Alternative
Inhibit, monoclonal antibody, NCI-H1650, NCI-H1975, Panitumumab (anti-EGFR), Panitumumab, human IgG2, Epidermal growth factor receptor, ErbB-1, EGFR, Inhibitor, HER1, ABX-EGF, Caco-2, anti-tumor, anti-EGFR, CHO, DLD-1
Target
EGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
19.7 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.31 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AS20 4408 100 µg
Anti-Delta-VPE | Vacuolar-processing enzyme delta-isozyme
Sign In for Pricing
View Details